| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein L4 | 0.839 | 0.231 | 1.1E-03 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
disease | 0.370 | None | 0.500 | 1 | 0 | 1996 | 2017 | ||||||||
|
glutamate ionotropic receptor kainate type subunit 2 | 0.561 | 0.769 | 1.00 |
|
disease | 0.350 | None | 0.667 | 1 | 0 | 1996 | 2017 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.400 | None | 0.709 | 1 | 0 | 1993 | 2019 | ||||||||
|
pericentriolar material 1 | 0.644 | 0.615 | 3.7E-16 |
|
disease | 0.380 | None | 0.750 | 1 | 0 | 2006 | 2019 | ||||||||
|
neurotrophin 3 | 0.519 | 0.808 | 0.93 |
|
disease | 0.400 | None | 0.778 | 1 | 0 | 1994 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.600 | None | 0.780 | 1 | 0 | 1995 | 2019 | ||||||||
|
neuregulin 3 | 0.670 | 0.615 | 0.11 |
|
disease | 0.600 | None | 0.786 | 1 | 0 | 2008 | 2020 | ||||||||
|
piggyBac transposable element derived 1 | 0.821 | 0.269 | 4.7E-10 |
|
disease | 0.430 | None | 0.800 | 1 | 0 | 2011 | 2014 | ||||||||
|
DiGeorge syndrome critical region gene 2 | 0.623 | 0.731 | 5.2E-06 |
|
disease | 0.350 | None | 0.800 | 1 | 0 | 2006 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 6 | 0.626 | 0.500 | 1.9E-04 |
|
disease | 0.400 | None | 0.824 | 1 | 0 | 1999 | 2018 | ||||||||
|
complexin 1 | 0.576 | 0.654 | 0.82 |
|
disease | 0.350 | None | 0.833 | 1 | 0 | 1998 | 2017 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.500 | None | 0.841 | 1 | 0 | 1992 | 2020 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.400 | None | 0.854 | 1 | 0 | 1998 | 2020 | ||||||||
|
reticulon 4 receptor | 0.595 | 0.692 | 0.96 |
|
disease | 0.670 | None | 0.857 | 0 | 0 | 2004 | 2017 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.859 | 3 | 0 | 1997 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.900 | limited | 0.865 | 4 | 0 | 2001 | 2019 | ||||||||
|
synaptophysin | 0.481 | 0.808 | 0.92 |
|
disease | 0.370 | None | 0.875 | 1 | 0 | 1995 | 2019 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.600 | None | 0.880 | 2 | 0 | 2003 | 2020 | ||||||||
|
glutamate metabotropic receptor 3 | 0.606 | 0.538 | 0.78 |
|
disease | 0.500 | None | 0.885 | 1 | 0 | 2002 | 2019 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 0.887 | 4 | 0 | 1984 | 2020 | ||||||||
|
vasoactive intestinal peptide receptor 2 | 0.619 | 0.692 | 4.7E-11 |
|
disease | 0.390 | None | 0.889 | 1 | 0 | 2011 | 2018 | ||||||||
|
monoamine oxidase B | 0.533 | 0.808 | 1.00 |
|
disease | 0.400 | None | 0.889 | 1 | 0 | 1996 | 2019 | ||||||||
|
synapsin II | 0.653 | 0.577 |
|
disease | 0.490 | None | 0.889 | 0 | 0 | 2000 | 2019 | |||||||||
|
glutamate metabotropic receptor 2 | 0.582 | 0.577 | 0.12 |
|
disease | 0.400 | None | 0.893 | 1 | 0 | 1995 | 2019 |